Latest News
NeuroSearch comments on sale of Pridopidine rights
20 April 2018 - Danish biotechnology company NeuroSearch A/S (CPH:NEUR) confirmed on Thursday that it is in discussions with regard to the potential sale of its rights to Pridopidine for a small seven figure amount in DKK.This is with reference to th...
Novartis reveals siponimod's efficacy on disability and cognition in secondary progressive MS patients
20 April 2018 - New analyses from Novartis' (VTX: NOVN) Phase III EXPAND study of oral, once-daily siponimod (BAF312) show it reduced the risk of disability progression in patients with secondary progressive multiple sclerosis (SPMS), the compan...
Allergan no longer interested in buying Shire
20 April 2018 - Allergan (NYSE: AGN) has revealed that it is not interested in buying Shire (LON: SHP) after all, Pharmaphorum reported on Friday.According to Shire, Takeda (TYO: 4502) has made three proposals since 29 March. Shire is said to have re...
Orphan Biovitrum names new head of human resources
20 April 2018 - Sweden-based Orphan Biovitrum (Sobi) has named Fredrik Wetterlundh as its head of human resources, it was reported yesterday.Wetterlundh is joining Sobi from Pfizer and most recently held the position of global human resources lead, g...
Sandoz and Pear Therapeutics to jointly commercialise and continue development of prescription digital therapeutics
20 April 2018 - Sandoz, a division of Novartis, and Pear Therapeutics are jointly commercialising and continuing development of novel prescription digital therapeutics designed to treat disease and improve clinical results for patients, it was report...